Apimeds Pharmaceuticals US, Inc. (APUS)
NYSEAMERICAN: APUS · Real-Time Price · USD
1.900
-0.030 (-1.55%)
At close: Sep 29, 2025, 4:00 PM EDT
1.900
0.00 (0.00%)
After-hours: Sep 29, 2025, 6:30 PM EDT
APUS Market Cap
APUS has a market cap or net worth of $23.89 million as of September 29, 2025.
Market Cap
23.89M
Enterprise Value
15.66M
1-Year Change
n/a
Ranking
Category
Stock Price
$1.90
Market Cap Chart
Since the IPO on May 9, 2025, APUS's market cap has decreased from $25.45M to $23.89M, a decrease of -6.11%. That is a compound annual growth rate of -15.17%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Sep 26, 2025 | 24.27M | 8.18% |
Sep 25, 2025 | 22.44M | -4.80% |
Sep 24, 2025 | 23.57M | -2.40% |
Sep 23, 2025 | 24.15M | -2.04% |
Sep 22, 2025 | 24.65M | -2.97% |
Sep 19, 2025 | 25.40M | 10.38% |
Sep 18, 2025 | 23.01M | 2.23% |
Sep 17, 2025 | 22.51M | -5.79% |
Sep 16, 2025 | 23.89M | -5.94% |
Sep 15, 2025 | 25.40M | -2.88% |
Sep 12, 2025 | 26.16M | 7.22% |
Sep 11, 2025 | 24.40M | -3.96% |
Sep 10, 2025 | 25.40M | -3.16% |
Sep 9, 2025 | 26.23M | 13.74% |
Sep 8, 2025 | 23.06M | -3.78% |
Sep 5, 2025 | 23.97M | 2.47% |
Sep 4, 2025 | 23.39M | -4.12% |
Sep 3, 2025 | 24.40M | 7.78% |
Sep 2, 2025 | 22.64M | -1.64% |
Aug 29, 2025 | 23.01M | -1.61% |
Aug 28, 2025 | 23.39M | -1.59% |
Aug 27, 2025 | 23.77M | 0.53% |
Aug 26, 2025 | 23.64M | -2.84% |
Aug 25, 2025 | 24.33M | -12.05% |
Aug 22, 2025 | 27.67M | -3.08% |
Aug 21, 2025 | 28.55M | 25.41% |
Aug 20, 2025 | 22.76M | -4.74% |
Aug 19, 2025 | 23.89M | 17.95% |
Aug 18, 2025 | 20.26M | 9.38% |
Aug 15, 2025 | 18.52M | 0.95% |
Aug 14, 2025 | 18.35M | -2.16% |
Aug 13, 2025 | 18.75M | 0.62% |
Aug 12, 2025 | 18.64M | 5.23% |
Aug 11, 2025 | 17.71M | -3.77% |
Aug 8, 2025 | 18.41M | 1.27% |
Aug 7, 2025 | 18.17M | -7.65% |
Aug 6, 2025 | 19.68M | 1.80% |
Aug 5, 2025 | 19.33M | 5.70% |
Aug 4, 2025 | 18.29M | -9.20% |
Aug 1, 2025 | 20.14M | - |
Jul 31, 2025 | 20.14M | -4.08% |
Jul 30, 2025 | 21.00M | -3.20% |
Jul 29, 2025 | 21.69M | -8.59% |
Jul 28, 2025 | 23.73M | -7.66% |
Jul 25, 2025 | 25.70M | 6.22% |
Jul 24, 2025 | 24.19M | -4.13% |
Jul 23, 2025 | 25.24M | 9.55% |
Jul 22, 2025 | 23.04M | -5.24% |
Jul 21, 2025 | 24.31M | 18.64% |
Jul 18, 2025 | 20.49M | -1.12% |
Jul 17, 2025 | 20.72M | -0.56% |
Jul 16, 2025 | 20.84M | 1.69% |
Jul 15, 2025 | 20.49M | -3.80% |
Jul 14, 2025 | 21.30M | 3.37% |
Jul 11, 2025 | 20.61M | -1.66% |
Jul 10, 2025 | 20.95M | 1.12% |
Jul 9, 2025 | 20.72M | 2.29% |
Jul 8, 2025 | 20.26M | -2.78% |
Jul 7, 2025 | 20.84M | 1.12% |
Jul 3, 2025 | 20.61M | 2.30% |
Jul 2, 2025 | 20.14M | -1.69% |
Jul 1, 2025 | 20.49M | 0.57% |
Jun 30, 2025 | 20.37M | -1.12% |
Jun 27, 2025 | 20.60M | 3.58% |
Jun 26, 2025 | 19.89M | 3.51% |
Jun 25, 2025 | 19.22M | 0.61% |
Jun 24, 2025 | 19.10M | -1.20% |
Jun 23, 2025 | 19.33M | 2.45% |
Jun 20, 2025 | 18.87M | -8.43% |
Jun 18, 2025 | 20.61M | -3.26% |
Jun 17, 2025 | 21.30M | -4.17% |
Jun 16, 2025 | 22.23M | 4.92% |
Jun 13, 2025 | 21.18M | -1.07% |
Jun 12, 2025 | 21.41M | 1.08% |
Jun 11, 2025 | 21.18M | -0.54% |
Jun 10, 2025 | 21.30M | -2.13% |
Jun 9, 2025 | 21.76M | -2.59% |
Jun 6, 2025 | 22.34M | 1.58% |
Jun 5, 2025 | 21.99M | 1.06% |
Jun 4, 2025 | 21.76M | -4.08% |
Jun 3, 2025 | 22.69M | 8.89% |
Jun 2, 2025 | 20.84M | 2.86% |
May 30, 2025 | 20.26M | 1.16% |
May 29, 2025 | 20.03M | 5.49% |
May 28, 2025 | 18.98M | -8.89% |
May 27, 2025 | 20.84M | -0.55% |
May 23, 2025 | 20.95M | -0.55% |
May 22, 2025 | 21.07M | 0.83% |
May 21, 2025 | 20.89M | -2.43% |
May 20, 2025 | 21.42M | 3.42% |
May 19, 2025 | 20.71M | 5.29% |
May 16, 2025 | 19.67M | -1.73% |
May 15, 2025 | 20.01M | -6.99% |
May 14, 2025 | 21.52M | 6.29% |
May 13, 2025 | 20.24M | -3.31% |
May 12, 2025 | 20.94M | -17.73% |
May 9, 2025 | 25.45M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 650.45B |
Johnson & Johnson | 432.80B |
AbbVie | 389.72B |
UnitedHealth Group | 311.62B |
Novo Nordisk | 242.68B |
Novartis AG | 238.65B |
Abbott Laboratories | 232.44B |
AstraZeneca | 228.75B |